Qitan Tech key facts
as of Oct 2026- Manufacturer of nanopore sequencing systems designed to enable real-time genetic analysis and molecular research.
- Qitan Tech is valued at approximately $690.2M as of Oct 2026 (last reported valuation).
- It has raised $198.9M; the latest was Later Stage VC in Dec 2025.
- Notable investors include GL Ventures, CDH Investments, Baidu Ventures, Orinno Capital, Yinxinggu Capital — 18 tracked in total.
- Status: Privately Held (backing).
Qitan Tech's last reported valuation, Dec 2022. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch Qitan Tech: the Monday email on marks, rounds and moves
Qitan Tech funding rounds
No funding rounds for Qitan Tech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Qitan Tech
18+Membership and data by Private Market View
Qitan Tech valuation
Qitan Tech's last reported valuation was $690 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.
Qitan Tech investors
18 investors are on record for Qitan Tech, including GL Ventures, CDH Investments, Baidu Ventures and Orinno Capital.
About Qitan Tech
Manufacturer of nanopore sequencing systems designed to enable real-time genetic analysis and molecular research. The company offers nanopore sequencers, portable and desktop platforms, flow cells, reagents, and sequencing software with long-read and real-time capabilities, enabling research institutions and medical laboratories to conduct efficient genomic analysis and accelerate biological research.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2016
- Employees
- 270
- Website
- qitantech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.